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Alzheimer's disease (AD) is nowadays regarded as only one part of the whole dementia 
scenario, that encompasses primary neurodegenerative dementias, vascular dementia and 
mixed dementias. The number of patients affected by dementia has been growing steadily 
over the last decade, and neurodegenerative processes are a significant threat and health 
burden for the elderly – it is estimated that by 2030, there will be more than 65 million 
people with dementia worldwide (Prince, Bryce et al. 2013). It is still unclear what is the 
relative contribution of amyloid plaques (50 - 80%?) and by vascular pathology (20 - 30%?) 
to the dementia epidemic (Abbott 2011): they usually coexist, to some variable extent, in 
brains of people with dementia, although neuro-pathological criteria for AD can be found in 
50% of the brains of aged individuals without cognitive impairment. Even in symptomatic 
individuals, there is poor correlation between severity of disease and anatomo-pathological 
burden (Wharton, Brayne et al. 2011). The link between vascular disease and AD is certain 
and probably strong (de la Torre 2012), but is neither simple nor entirely clear, with a 
blurred pathological divide between cognitive decline and normal brain and vessel aging 
(Picano, Bruno et al. 2014). 
 
 
The vascular basis of brain aging and dementia 
 
With normal aging, both cognitive function and cognitive reserve decline. Cognitive reserve 
refers to the brain's ability to cope with either increasing activities or damage. The concept 
of cognitive reserve is a predominantly functional one. It follows the concept that brain 
plasticity allows increasing brain connectivity after mental exercise, all throughout life, and 
this prolongs maintenance of function despite cell degeneration in older life. There is a 
threshold after which cognitive reserve finishes and cognitive impairment becomes evident 
(Snowdon and Nun 2003). 
Normal aging causes brain atrophy, with MRI studies showing a 4% reduction in brain 
volume for every 10 years above age 65 (Fotenos, Mintun et al. 2008). This para-
physiological descent is earlier and steeper in neurodegenerative diseases. Vascular reserve 
refers, in its turn, to the vessels’ ability to cope with increasing activity or damage, and is 
commonly measured as the ability to increase regional flow after a hyperemic stimulus, 
such as carbon dioxide in the brain, adenosine in the myocardium or ischemia in the 
forearm; the cerebral, coronary and systemic vascular flow reserve also decline with aging 
(Taddei, Virdis et al. 1995, Galderisi, Rigo et al. 2012). Since it is unable to store energy, 
the brain depends on continuous delivery of oxygen and glucose through blood flow. Under 
physiological conditions, essential for neuronal functional activity, there is a systematic 
coupling between activation of specific brain function and microcirculation flow activation, 
within the concept of the neurovascular unit with microvessels, endothelial cells, neurons 
and glial cells all closely integrated with continuous bidirectional signaling (Iadecola 2010, 
Del Zoppo 2013). The brain is a high-flow, low-impedance organ with a high metabolic 
rate, and typically receives 15% of total cardiac output and 25 to 50% of total body glucose 
utilization, despite accounting for only 2% of total body weight (Fehm, Kern et al. 2006, 
Wolff 2007). Blood flow is normally autoregulated, meaning that flow remains relatively 
constant over a wide range of mean perfusion pressures. If blood pressure falls below a 
certain point, termed the lower limit of autoregulation, cerebral blood flow decreases. 
Because of the high metabolic demand for oxygen in the brain, limited cerebral blood flow 
may lead to an energy crisis in the neurovascular unit (de la Torre 2012): cerebral 
hypoperfusion could be an early event in the cascade leading to cognitive decline.  
 
For several decades the traditional classification of dementia have distinguished those forms 
of clinically relevant cognitive impairment in which the evidence of stroke or subclinical 
vascular brain injury can be identified (namely vascular cognitive impairment, VCI) from 
AD, describing different pathophysiological pathways in the two conditions. More recently, 
de la Torre hypothesized that AD can be viewed as a predominantly vascular disorder (de la 
Torre 2002). The hypothesis was based on several converging lines of evidence, including: 
1) epidemiological studies showing that AD shares with cardiovascular disease a number of 
risk factors (from hypertension to diabetes) and virtually all risk factors for AD also lower 
cerebral perfusion (Kaffashian, Dugravot et al. 2013); 2) detection of regional cerebral 
hypoperfusion with the use of neuroimaging techniques is capable to identify AD candidates 
preclinically; 3) regional microvascular abnormalities in the brain appear before 
hypometabolism, cognitive decline and neurodegenerative changes; 4) clinical overlap 
between AD and vascular dementia; 5) improvement of cerebral perfusion is obtained from 
drugs (such as cholinesterase inhibitors) used to reduce the symptoms of AD  in patients 
who respond to treatment (Geaney, Soper et al. 1990, Van Beek and Claassen 2011). 
However, the interpretation of the cause-effect relationship between hypoperfusion and 
cognitive decline remains uncertain, since decreased flow could be interpreted as a mere 
consequence of reduced neuronal activity. The reverse could also be true, turning cerebral 
hypoperfusion from bystander to killer – and a potential target of therapeutic intervention. 
Evidence supporting the vascular contribution to AD has been reinforced and extended in 
the last decade. Brain and vessel premature aging share similar molecular, cellular and 
tissue mechanisms, such as abnormal intracellular calcium handling, epigenetic DNA 
damage, and low-level systemic and local inflammation with altered redox state (Pizza, 
Agresta et al. 2011), with imbalance between reduced trophic-protective factors and 
increased inhibitory factors and reduced endothelial nitric oxide production. AD and 
atherosclerosis show several common signaling pathways, with common genes, common 
miRNA family, and common molecular links. However, the clinical diagnostic and 
therapeutic implications of this improved understanding of the disease remain elusive, and 
usually no systematic cardiovascular workup is yet recommended in AD (Picano, Bruno et 
al. 2014). 
 
 
Links between cardiovascular disease and cognitive impairment: a patho-physiological 
perspective 
 
Changed cardiovascular conditions can induce changes in organs and above all in brain 
perfusion (Cipolla 2009), possibly one of the determinants of cognitive impairment. The 
system can be conceptualized as a chain: normal brain perfusion requires that all rings of the 
physiological chain be intact, since a chain can only lift the weight that its weakest link can 
bear. In this simplified description of cardiovascular hemodynamics, it is possible to 
identify distinct segments in series, contributing to normal perfusion with well-oxygenated 
blood in the healthy aging brain: the lungs, the heart, the large elastic vessels (aorta) 
(Muqtadar, Testai et al. 2012), the cerebrovascular arteries (carotid, middle cerebral and 
vertebral arteries) (Demarin and Morovic 2014), the small cerebral vessels (contributing to 
50% of the overall cerebral resistance of the healthy brain) (Ostergaard, Aamand et al. 
2013), and the cerebrospinal venous system. An anatomic or functional alteration of each 
segment can lead to impaired cerebrovascular perfusion and increased risk of dementia, 
although frequently these conditions are not isolated and are often mutually interrelated. 
The risk of critical cerebral hypoperfusion increases in a clinically relevant way when each 
of the rings of the adequate cardiovascular cerebral perfusion chain is weakened. No matter 
how brain hypoperfusion occurs, it may eventually enter a final common pathological 
pathway, provoking β-amyloid (Aβ) accumulation (Zlokovic 2011). Effective therapeutic 
interventions targeting cardiovascular disease might beneficially affect cognitive decline 
(Picano, Bruno et al. 2014).  
 
 
Cerebrovascular disease 
 
Cerebrovascular disease is recognized as the pathophysiological basis for VCI, ranging from 
mild impairment to full-blown dementia. Its clinical manifestations range from overt, 
repeated strokes to dementia accompanied by neuroimaging findings, showing brain small 
vessel disease (SVD) including dilated Virchow-Robin spaces, micro-infarcts, white matter 
degeneration and microbleeds. Indeed, neuroimaging abnormalities can be found in both 
AD and VCI, as well as in asymptomatic individuals (Gorelick, Scuteri et al. 2011). 
Both micro- and macrocirculation can be involved. At pathology verification, 
atherosclerotic changes in circle of Willis and intracranial arteries are more extensive in AD 
than in people without dementia (Roher, Tyas et al. 2011). Atherosclerosis of the 
extracranial carotid arteries is associated with increased prevalence of both vascular and AD 
dementia in the Rotterdam study population (Hofman, Ott et al. 1997). Arteriolosclerosis 
and, more in general, cerebral SVD, are also involved in cognitive impairment and they are 
thought to be a major component of degenerative brain disease. Age and hypertension 
appear to be the main factors inducing microvascular rarefaction and remodeling, but also 
AD, cerebral amyloid angiopathy and hereditary small-vessel syndromes are associated to 
SVD and contributors to VCI (Brown and Thore 2011, Gorelick, Scuteri et al. 2011, Picano, 
Bruno et al. 2014). 
 
Clinical implications: diagnosis and therapy of the vascular component of cognitive 
impairment 
 
A thorough evaluation of patients with cognitive impairment should systematically include 
the assessment of the cardiovascular rings of the chain linking blood perfusion to brain 
function: this systematic screening may also lead to identification of potentially treatable 
factors enhancing cognitive decay. In middle-age subjects, an abnormally high pressure is a 
risk factor for long-term development of dementia, and antihypertensive therapy may 
protect from hypertension-associated dementia (Levi Marpillat, Macquin-Mavier et al. 
2013). However, in elderly patients the risk of mental deterioration may be enhanced also 
when diastolic pressure becomes too low, since the relationship between blood pressure and 
cognitive function appears to be curvilinear, so that a low diastolic and mean blood pressure 
are associated with more progression of sub-cortical brain atrophy in patients with manifest 
arterial disease (Jochemsen, Muller et al. 2013). Cerebrovascular disease can involve both 
large and small vessels. Elderly symptomatic patients with severe carotid lesions, easily 
diagnosed by ultrasound, had significant improvement in cognitive performance scores after 
carotid endarterectomy (Baracchini, Mazzalai et al. 2012). Cerebral small vessel disease can 
be indirectly detected through its functional consequences via transcranial Doppler 
sonography, which, although not as accurate as computed tomography or MRI imaging, is a 
non-invasive imaging technique assessing mean arterial blood flow velocity (an accepted 
proxy for cerebral blood flow) and the pulsatility index (a surrogate for cerebrovascular 
resistance and intracranial compliance). Patients with AD have a reduced cerebral blood 
flow velocity and increased pulsatility index, and these changes are even more obvious in 
vascular dementia (Sabayan, Jansen et al. 2012).  
 
Endothelial cells seem to play a major role in maintaining the integrity and homeostasis of 
the blood-brain barrier. Endothelial nitric oxide (NO) is a known major vasodilator playing 
a key role in regulating local blood flow, and is altered in many vascular conditions. 
However, endothelial NO has also shown the ability to affect synaptic plasticity, 
mitochondrial biogenesis, and function of neural progenitor cells, also modulating 
processing of amyloid precursor protein. It has been suggested that endothelial NO could be 
the key molecule linking cerebrovascular and neuronal function and the “protector of a 
healthy mind” (and also of a healthy vessel, probably a prerequisite for the preservation of a 
healthy mind) (Katusic and Austin 2014). In particular, reduced bioavailability of NO 
promotes the formation of amyloid plaques: in the neural cells, it increases the production of 
both amyloid precursor protein (APP) and its cleavage enzyme; in the microglia, it favors a 
pro-inflammatory phenotype. In its turn, Aβ deposition causes endothelial dysfunction in 
the brain circulation through an increase in reactive oxygen species as byproduct of 
NADPH oxidase (Zlokovic 2011). The maintenance of cerebrovascular endothelial function 
through regular exercise and healthy lifestyle is a key element for successful brain aging 
(Bolduc, Thorin-Trescases et al. 2013, Picano, Bruno et al. 2014). 
 
 
Arterial stiffness and cognitive decline 
 
Stiffening of large arteries occurs with aging. It reduces the buffering capacity of the arterial 
tree; thus, peripheral circulation and small vessels are subject to increased flow and pressure 
pulsatility. This is especially dangerous for organs such as the brain and the kidney, which 
are characterized by torrential flow and very low resistances, with lower defense against 
large, and possibly deleterious, oscillations in pressure with the cardiac cycle. Arterial 
stiffening is, indeed, associated with brain damage (Waldstein, Rice et al. 2008); high pulse 
pressure (particularly at the central level), whose arterial stiffness is a major determinant, is 
also associated with brain damage (Waldstein, Rice et al. 2008).  It is known that an 
increase in arterial stiffness is a major risk factor for dementia (de la Torre 2002, 
Luchsinger, Reitz et al. 2005, Waldstein, Rice et al. 2008, Zlokovic 2011). Indeed, a higher 
aortic stiffness is associated to a steeper decline of cognitive function over time (Waldstein, 
Rice et al. 2008, Mitchell 2011, Mitchell, van Buchem et al. 2011, Pase, Herbert et al. 
2012), although neutral results were found for carotid stiffness (Poels, van Oijen et al. 
2007). Carotid plaques and intima-media thickness are associated with cognitive decline 
(Wendell, Zonderman et al. 2009), and reduced carotid distensibility might cause cerebral 
vascular damage by increasing the transmission of flow and pressure pulsatility to the 
cerebral microcirculation (O'Rourke and Safar 2005) and by favoring plaque rupture and 
embolization (Paini, Boutouyrie et al. 2007). Improved carotid distensibility might therefore 
contribute to reduce vascular contribution to dementia pathogenesis. In a recent meta-
analysis a significant improvement in aortic stiffness was observed in response to aerobic 
exercise training (Ashor, Lara et al. 2014), while results regarding carotid stiffness are few 
and less consistent (Kitzman, Brubaker et al. 2013, Tanahashi, Akazawa et al. 2014).  
In this framework, the use of biomarkers such as arterial stiffness and endothelial function, 
sensitive to the integrated effect of the sum of a number of cardiovascular risk factors over 
time directly on their main target, the arterial tree, is appealing, since it would allow 
identifying individuals at risk not only for cardiovascular events, but also for cognitive 
decline. Improved arterial function and distensibility might contribute, on its turn, to reduce 
vascular contribution to dementia pathogenesis. 
Driven by a better understanding of underlying mechanisms, the core of therapeutic 
intervention can shift from individual treatment to aggressive prevention of environmental 
causes, with both individual and social benefits.  
 
 
Environmental nurturing of brain and vessel plasticity 
 
Environment can both protect and damage the aging brain and modulate vessel plasticity. 
Many factors exert their influence in a similar direction for both brain and vessel function. 
Premature brain and vessel aging can be promoted by environmental factors such as 
sedentary lifestyle, heavy ecosystem pressure (high urban and industrial pollution, 
agriculture, military and medical toxicants), “brain drain” (stress, isolation, depression), and 
eating habits (overeating, junk food).  
Environmental enrichment (EE) profoundly affects the central nervous system at the 
functional, anatomical and molecular levels, during the critical early growth period, during 
adulthood, in the aging brain and even in neurodegenerative states, such as early AD. The 
efficacy of this therapeutic approach has been demonstrated in the experimental setting 
(Sale, Berardi et al. 2014), although more clinical data are needed, and a recent US National 
Institute of Health Consensus panel on AD concluded that it is too soon to tell whether 
lifestyle changes including physical, cognitive, sensory, and social training or any other 
prevention strategy can affect the development or course of AD (Deweerdt 2011). 
Lifestyle changes are likely to have only limited benefit if overt dementia is enrolled, 
without exclusion of patients with important comorbidities. On the contrary, benefits might 
be magnified in early stages of disease without critical comorbidities.  
Even small gains in cognitive function or slight delays in the development of symptoms 
could greatly reduce the burden of disease. Obviously, an aging brain in the pre-dementia 
stage cannot have the same synaptic and vascular plasticity as a healthy adult brain, which 
even in normal conditions will suffer a 20% reduction in functional capacity by about 68 
years of age. However, assuming that environmental enrichment might produce a reduction 
of the rate of decline of only 0.1% per year from young adulthood onward, such a functional 
decline would then be delayed until age 88. Negative environmental nurturing could, on its 
turn, advance the 20% cognitive decay to the age of 58. In addition, the same lifestyle and 
environmental factors modulating cognitive function also modulate vascular function. 
This model explains why even trivial improvements can add up over time to exert 
significant consequences for the individual. The recommendations of neurobiologists to 
prevent cognitive decay by lifestyle and environmental intervention closely mirror those of 
cardiologists to prevent progression of vascular disease: quitting smoking, achievement and 
maintenance of ideal body weight, regular exercise, reduced intake of saturated fats and 
sugars, and decreasing the level of stress, which is best achieved by improving one's family, 
community, and society relationships (Fihn, Blankenship et al. 2015). An integrated 
physical, cognitive, and dietary program of environmental enrichment allows the 
neurobiologist and the cardiologist to kill but two birds (brain and vessel protection) with 
one stone (lifestyle changes).  
To date, research on nonpharmacological treatment for AD and VCI is limited, despite 
preliminary evidence that these approaches are no less efficacious than the antidementia 
drugs (Pitkala, Poysti et al. 2013): exercise programs (Forbes, Forbes et al. 2015), cognitive 
intervention (Reijnders, van Heugten et al. 2013) and sensorial enrichment (Kverno, Black 
et al. 2009), either alone or combined (Fiatarone Singh, Gates et al. 2014) can slow the 
progression of MCI and AD, with a beneficial impact on health care costs (Pitkala, Poysti et 
al. 2013). 
 
In the end, it remains uncertain whether AD is a vascular disorder with neurodegenerative 
consequences or a neurodegenerative disorder with vascular consequences. It is certain that 
the cardiovascular system and the central nervous system are two complex systems whose 
functions are deeply intertwined, with similar processes participating in the phase of 
involution, the same markers indicating vulnerability to decay, and possibly similar factors 
slowing progression and promoting resilience to disease. The concepts of pure vascular and 
pure neuro-degenerative dementia have been replaced with the recognition that most 
patients exhibit a spectrum of neurodegenerative and vascular processes (Viswanathan, 
Rocca et al. 2009, Zlokovic 2011), suggesting that the disorder might, at least in some 
instances, be secondary to cerebrovascular disease (Picano, Bruno et al. 2014).  
 
 
The Train the Brain study 
 
Within this framework, the Italian National Research Council (CNR) launched a 
prospective, randomized, parallel-group, open-label clinical trial called “Train the Brain”, 
and enrolled (between March 2012 and January 2014) 118 patients (aged 69 - 89 years) with 
Mild Cognitive Impairment, who were then randomized to standard vs. environmental 
enrichment therapy. In the enrollment phase, a thorough cardiovascular characterization 
(including resting echocardiography, flow-mediated dilation of brachial artery and aortic 
stiffness) was performed, in order to better define the study cohort from the cardiovascular 
viewpoint. A complete clinical, neuropsychological and brain (anatomic, perfusion and 
functional) MRI assessment was performed at study entry, then following the 7-month 
period. The study was aimed at providing insight into the neuropsychological, cerebral 
microvascular and cardiovascular alterations present in mild cognitive impairment, as well 
as their modification by an environmental enrichment program. 
The intervention involved a 3-h environmental enrichment session 3 times a week for 7 
months, consisting of tailored, stepwise physical, cognitive and social training, including 
music therapy and dance, under the close supervision of highly specialized personnel in an 
ad-hoc facility built within the Pisa CNR Research campus. 
 
 
 
A clinical and experimental study of the efficacy of cognitive training and physical exercise 
in dementia 
 
Age-dependent cognitive decline is a highly impacting problem at the clinical, economical 
and assistance level. Age, indeed, is the major risk factor for dementia. In Italy there are 
around 700.000 patients diagnosed with dementia and around 100.000 new cases every 
year. 
At present, there are no effective therapeutic strategies for dementia, a pathology practically 
orphan of treatment. It is therefore more and more evident the need of strategies aimed at 
preventing or slowing down cognitive decline, starting from the early stages of the disease. 
The Train the Brain project assesses the efficacy of a combination of physical exercise and 
cognitive training in slowing down the progression of symptoms in subjects at risk of 
dementia.  
 
Several studies in humans have demonstrated that the exposure to a cognitively and socially 
stimulating environment and physical exercise have beneficial effects on brain functioning, 
especially in the elderly, and reduce the risk of developing dementia (Fratiglioni, Paillard-
Borg et al. 2004, Marx 2005, Kramer and Erickson 2007). The estimated reduction in the 
risk of developing dementia varies from study to study but generally ranges between 20 and 
50%. 
In parallel, a large number of studies performed in animal models has demonstrated that EE 
– physical exercise and exposition to a cognitive and socially stimulating environment – 
ameliorates cognitive performance, slows down the decline associated with aging, is 
neuroprotective, and enhances neural plasticity (Mainardi, Di Garbo et al. 2014). EE 
ameliorates cognitive deficits in animal models of AD (Jankowsky, Melnikova et al. 2005). 
These results show the EE potential as non-pharmacological therapeutic strategy to prevent 
the onset of cognitive deficits, but studies on the efficacy of a combined physical and 
cognitive intervention in subjects with dementia are few and present methodological limits. 
An important point that has recently emerged both from the human and animal research, is 
that the combination of physical and cognitive activity seems to have additive effects on 
brain plasticity and age related cognitive decline (Fabel, Wolf et al. 2009, Paillard-Borg, 
Fratiglioni et al. 2012) (Fiatarone Singh, Gates et al. 2014). In this line, a very important 
study is that by Ngandu et al., 2015 (Ngandu, Lehtisalo et al. 2015). More than 1250 elders, 
with cognition in the mean level for age, were randomized to a two-year multidomain 
intervention of diet, exercise, cognitive training, and vascular risk monitoring versus 
control. Findings show that global cognitive status, executive functions and processing 
speed improved more in the intervention than in the control group, suggesting that a 
multidomain intervention could indeed improve or maintain cognitive functioning in elders.  
 
Evidences from the experimental and clinical literature indicate that mild cognitive 
impairments and the presence of subtle cerebral alterations, detectable with techniques such 
as structural and functional neuroimaging, precede of several years the clinical onset of 
dementia (Garrett, Browndyke et al. 2004, Jones, Laukka et al. 2004, 2008). This early stage 
of the disease is referred to as Mild Cognitive Impairment (MCI). In the majority of cases, 
MCI heralds overt dementia, with a rate of yearly progression to dementia of MCI subjects 
being much higher (up to 20 times more frequent) than in the non-MCI elderly, so much 
that about 70% of MCI cases develop overt dementia within a period of five years. It is 
believed that in the preclinical phase of dementia a progressive loss in the number, efficacy 
and modifiability of synaptic connections. The progression of these alterations and the 
manifestation of this loss in terms of clinical signs would be contrasted by plastic 
reorganizations within the brain that tend to compensate for the reduced density and 
functionality of synapses and that increase neural plasticity, favoring the establishment and 
recall of memory traces. A precocious identification of MCI would allow initiating a 
therapeutical / rehabilitative intervention precociously, making it possible to maximally 
exploit the remaining potential for plasticity in the brain. This would markedly strengthen 
the efficacy of interventions aimed at prevent the progression of these subjects toward a 
condition of severe dementia. 
The scientific hypothesis underlying this project is that interventions including physical 
exercise and cognitive stimulation can significantly affect the cognitive decline in subjects 
at risk for developing dementia. This goal, if achieved, would determine a delay in the loss 
of self-sufficiency and, therefore, an increase in the quality of life of the patients and 
caregivers, resulting in a net reduction of the direct and indirect costs associated with 
continuous assistance, and without risks of collateral effects. 
 
The primary aim of the Train the Brain study was therefore to assess the efficacy of a 
protocol of physical exercise and cognitive stimulation on the progression of the disease in 
subjects at risk of dementia, identified through an advanced battery of diagnostic tests, with 
the aim to develop a nonpharmacological preventive/therapeutic strategy easily applicable 
to humans and exploitable by the National and Regional Health Service. 
 
 
 
  
Methods 
 
Study protocol  
 
The eligible population for the study included elderly subjects (65-89 years) with Mild 
Cognitive Impairment confirmed at the neurological examination; severe neurological 
pathologies such as brain lesions or conditions barring participation to the cognitive or 
physical training program were the only substantial exclusion criteria.  
Phase 1 - Patient recruitment and baseline cognitive evaluation: General Practitioners of Pisa 
Municipality were instructed to select subjects aged 65 to 89 years, in good health, with no 
significant cerebral vascular disease, psychoses, depression, dementia or mental retardation. 
A preliminary questionnaire regarding memory troubles (MAC-Q) was self-administered. 
These potentially eligible subjects underwent a clinical confirmation with a set of 
neuropsychological tests, which also provide the baseline cognitive status, and a 
comprehensive collection of medical history and physical, cognitive, and affective 
examination. Subjects with a confirmed diagnosis of MCI and matching inclusion criteria 
were enrolled in the study and randomly assigned either to intervention or control group; all 
enrolled subjects underwent baseline instrumental evaluation.  
 
Recruitment was performed using a two-phase scheme consisting of a screening phase, to 
identify subjects with possible cognitive impairment, and a neuropsychological evaluation of 
subjects screened as positive to confirm or reject the diagnosis of Mild Cognitive Impairment. 
The screening evaluation, phase 1, includes:  
• Mini Mental State Examination (MMSE), largely used to screen for cognitive impairment 
and to estimate severity;  
• Clock Drawing Test (CDT), as a valid screening method for Mild Cognitive Impairment;  
• Clinical Dementia Rating Scale (CDR), a structured interview with the patient and an 
informant, used to quantify the severity of symptoms of dementia;  
• Geriatric Depression Scale (GDS) a self-report assessment used to identify depression in the 
elderly.  
To be eligible for phase II, all participants had to meet the following operational criteria:  
1) CDR of 0.5 or 1, with at least a 0.5 in the memory domain and with MMSE score greater 
than or equal to 24 and CDT score greater than 8;  
2) a CDT score lower or equal than 8, even if CDR equal 0 and MMSE score greater than or 
equal to 24;  
3) Geriatric Depression Scale (GDS) score lower than 9.  
Subjects sufficiently impaired, cognitively and functionally, to meet criteria for dementia 
were excluded. 
Phase 2 - Baseline instrumental evaluation: evaluation of brain volumetry and function (MRI, 
fMRI); cardiovascular assessment;  
Phase 3 - Intervention, 7 months: the physical training protocol consists of aerobic physical 
activity undertaken for 1 hour per session, three times per week, under the supervision of 
trained and experienced personnel, including physiotherapists and personal trainers. The 
protocol includes a combination of aerobic exercises and of callisthenic exercises for 
muscular strengthening, balance and joint flexibility improvement. In broad terms, each 
session was structured with a first session of callisthenic exercise, a second session of aerobic 
exercise on exercise bicycle and a third session of cool-down.  
For the cognitive training, patients participated to the selected activities two hours per session, 
three times per week. The adopted cognitive training program was based on a mixed strategy 
which provides alternation between single-modality training sessions and sessions of 
recreational and leisure cognitive activities. Single-modality training activities are designed 
specifically to stimulate cognitive functions such as memory, attention, verbal fluency and 
executive functions. The recreational and leisure activities are intended to promote a context 
of multimodality training in a context of increased socialization and interpersonal exchange, 
in order to arouse curiosity and participation and to reduce the anxiety level linked to an 
excessive repetition of single modality activities. In addition, one hour music therapy session 
was performed once a week. The program also included lessons aimed at implementing 
compensatory strategies for maintaining a good performance in cognitive processes such as 
memory, attention, metacognition and thinking.  
Phase 4 - T7, End of intervention: both groups, intervention and control, underwent a 
complete baseline-like (neuropsychological and instrumental) re-evaluation after 7 months of 
training/usual care.  
 
 
Neuropsychological assessment  
 
The protocol investigation of phase II consisted of a neuropsychological assessment of 
cognitive functions in order to identify MCI. The diagnostic criteria for MCI proposed by 
European Consortium on Alzheimer’s Disease Working Group on MCI (Winblad, Palmer et 
al. 2004, Portet, Ousset et al. 2006) were applied:  
(1) Cognitive complaints corroborated by an informant;  
(2) The reporting of a decline in cognitive functioning relative to previous abilities during the 
past year by the patient or informant;  
(3) Cognitive disorders as evidenced by clinical evaluation (impairment in memory or in 
another cognitive domain);  
(4) no or minimal impairment in activities of daily living as determined by a clinical interview 
with the patient and informant (ADCS MCI-ADL Scale), a modification of the ADCS-ADL 
Scale designed to increase sensitivity to impairments in instrumental activities that may occur 
in MCI.  
A final clinical diagnosis had to be confirmed by the results of both the neuropsychological 
examination and the clinical evaluation. Patients diagnosed as MCI underwent a psycho-
behavioural evaluation, which included the following scales:  
• Alzheimer's Disease Assessment Scale-cognitive (ADAS-Cog) (Fioravanti, Nacca et al. 
1994) to measure the severity of the most important symptoms of AD;  
• Neuropsychiatric Inventory (NPI), a scale administered to the informant, to evaluate severity 
and frequency of 12 neuropsychiatric disturbances common in dementia;  
• Memory Functioning Questionnaire, a questionnaire of 18 items with a score ranging from 
1 to 7 for each item, the lowest score meaning the higher use of mnemonics strategies.  
The complete neuropsychological evaluation and ADAS-Cog administration has been 
performed at the start of training (T0) and at the end of training (T7).  
Note that the ADAS-Cog score is computed so that the more severe the cognitive deficit, the 
higher the score, with low values meaning better cognitive function; i.e., the lower the better. 
  
 
 
 
Cognitive training  
 
Enrolled subjects were assigned to mixed-gender classes of 10 subjects each and given two 
sessions of cognitive training of 60 min each per day, three times a week, every other day 
from Monday to Friday (for a total of six hours per week). The cognitive training programme 
was based on eight cycles; each cycle was composed of 18 sessions of cognitive stimulation, 
with exercises and activities aimed at stimulating multiple cognitive functions. Each cycle 
lasted three weeks, after which the same kind of cognitive stimulation sessions were re-
started, with exercises and activities of increased complexity compared to the previous cycle.   
Each cycle was structured in sessions aimed at stimulating the following main functions: 
acoustic attention, visual attention, visual memory, imagination, orientation and spatial 
memory, personal and temporal orientation, verbal memory, lexical abilities, memory for 
terms and meanings, affective memory, memory for texts, memory for faces and names, logic. 
Each cycle lasted with a theoretic-strategic lesson given by the cognitive trainers and focused 
on specific cognitive processes, such as memory, learning, attention, meta-cognition.  
During the various sessions, there was an alternation of paper and pencil tests, social games, 
and multimedia-computer exercises, and the cognitive training was based on a balanced 
alternation of sessions for single cognitive modality and sessions focused on multimodal 
activities. Single modality sessions were aimed at intensively stimulating specific cognitive 
domains, such as memory, attention and executive functions. Multimodal activities were 
aimed at reconstructing a more ecological environment for the enrolled subjects, in order to 
favour socialisation and interpersonal exchanges in an enriching context. Alternation between 
the two types of sessions allowed maintaining an active participation in the enrolled subjects, 
stimulating their curiosity and attention and reducing levels of anxiety and potentially 
negative stress factors. Moreover, an alternation between sessions for single cognitive 
modality and multimodal activities was also aimed at avoiding habituation processes and at 
favouring diffuse and generalised brain stimulation, in order to maximise the chance to 
positively impact on the subject everyday life. In order to monitor performance improvement 
during the seven months of training, subjects were given frequent examination tests aimed at 
assessing their abilities in key cognitive function domains. Once a month, a session of movie 
watching and discussion was given to all classes together. 
 
Music therapy 
 
Once a week, subjects of each class attended together a session of one-hour music therapy, 
during which they were involved both in listening activities and also directly engaged in 
singing, playing musical instrument and rhythmic movements.  
 
 
Physical training 
 
Supervised seven-month aerobic exercise training was performed in a Fitness Centre built on 
purpose within the National Research Council Area of Research in Pisa. The participants 
attended one-hour lessons three times per week in small groups with a maximum number of 
10. Each lesson was planned according to the American College of Sports Medicine 
guidelines and included aerobic exercise on an ergometer cycle, whose duration was increased 
gradually from 10 to 20 minutes as the participants progressed through the exercise 
intervention, followed by exercises targeted to improve muscle strength, physical function 
(static and dynamic), neuromuscular control and flexibility.  
 
 
Endothelium-dependent and -independent vasodilation in the brachial artery 
 
Endothelium-dependent response was assessed by flow mediated dilation (FMD) (Ghiadoni, 
Salvetti et al. 2015). Briefly, a pediatric cuff was positioned around the right forearm and 
the right brachial artery was located and scanned using a 10 MHz linear array transducer 
(MyLab 25, ESAOTE Florence, Italy). After one minute of baseline recording, the cuff was 
inflated at 250 mmHg for five minutes, and then deflated to induce reactive hyperemia. 
Endothelium-independent vasodilation was obtained by the sublingual administration of 25 
µg GTN. Brachial artery diameter and flow velocity were continuously monitored by 
computerized edge detection system (Cardiovascular Suite; Quipu srl, Italy). FMD and 
response to GTN were calculated as the maximal percent increase in diameter above 
baseline.  
 
Aortic and carotid stiffness 
 
Arterial tonometry was performed according to international recommendations (Van Bortel, 
Laurent et al. 2012). Carotid-femoral pulse wave velocity (PWV) was assessed by 
SphygmoCor device (AtCor Medical: Sidney, Australia), recording waveforms at the two 
recording sites, sequentially. PWV was calculated as the ratio between the subtracted 
distance between the two recording sites and wave transit time. Applanation tonometry was 
also performed on the radial artery in order to obtain central blood pressure values, by using 
a validated transfer function (SphygmoCor, AtCor Medical: Sidney, Australia), and 
augmentation index (AIx). Three consecutive measurements were recorded and the median 
value was considered. Carotid systolic BP and pulse pressure (PP) were then obtained from 
carotid pressure waveform, using central diastolic and mean BP for calibration.  
Scans of the common carotid artery were obtained by high-resolution ultrasound with a 10 
MHz linear array transducer (MyLab25; ESAOTE, Florence, Italy). Two 10’-clips were 
acquired from each common carotid artery (1 cm proximal to the carotid bulb in a region 1 
cm-wide and free of plaques) and then analyzed offline by means of Carotid Studio (Quipu 
srl, Pisa, Italy), an algorithm for the automatic evaluation of the instantaneous carotid 
diameter. The method is based on a well-validated contour tracking technique, allowing 
automatic evaluation of diameter stroke changes during the heart cycle, and was validated 
for accuracy against the gold standard measurement by radiofrequency (Bianchini, Bozec et 
al. 2010). Carotid lumen area was derived from the diameter values, assuming the cross-
section of the artery to be circular. Common carotid intima-media thickness (IMT) was 
automatically measured on the same image sequences as the mean of the relative values of 
the last 10 seconds. Wall cross-sectional area (WCSA) was computed combining the values 
of diameter and IMT. The following parameters were calculated:  
- carotid distension (D), that is the stroke change in diameter, calculated as the difference 
between the systolic and diastolic values;  
- cross-sectional distensibility coefficient (DC), calculated as DC = ΔA / ( A * carotid PP ), 
where A is the diastolic lumen area, and ΔA is the stroke change in lumen area;  
- carotid stiffness (CS), calculated by using the Moens-Korteweg equation, ( ρ * DC ) –1/2, 
where ρ is the blood density; 
- cross-sectional compliance coefficient (CC), i.e. the absolute change in lumen area during 
systole for a given pressure change (CC = ΔA / carotid PP); 
- Young's elastic modulus or incremental elastic modulus (Einc), a measurement of intrinsic 
stiffness of the vessel wall components, calculated as Einc = [ 3 ( 1 + A / WCSA ) ] / DC. 
All parameters were considered as the mean of the right and left common carotid, except 
when the analysis at one time point was viable for one vessel only: in this case, that side 
was the only one considered in subsequent analyses. 
 
 
Echocardiography 
 
Echocardiography was performed using a commercially available portable echo machine 
(Vivid I, General Electric Healthcare Clinical System) with a 2.5-3.5 MHz phased-array 
transducer, second harmonic technology. Linear internal measurements of the left ventricle 
(LV) and its walls were performed in the parasternal long-axis view, perpendicular to the 
LV long axis and measured at or immediately below the level of the mitral valve leaflet tips, 
according to current guidelines, and used to calculated LV mass. LV end-systolic and end-
diastolic volumes were measured from the apical four- and two-chamber views and ejection 
fraction (EF) was calculated by the modified biplane Simpson’s rule. Mitral regurgitation 
was assessed semi-quantitatively, from 0 to 3. Each parameter was measured as the average 
of at least three consecutive beats. All measurements were performed according to the 
recommendations of the European Association of Echocardiography / American Society of 
Echocardiography (Lang, Badano et al. 2015). 
 
 
 
  
Results 
 
MCI vs. non-MCI 
 
One hundred thirty-eight elder subjects completed the cardiovascular evaluation at baseline. 
98 were defined as having MCI at the neurological examination; 40 were not. 
Results are shown in Table 1. The two groups showed no significant difference in terms of 
age, BMI or blood pressure. No difference was found in carotid-femoral pulse wave 
velocity, central pressures or parameters from pulse wave analysis. 
Flow-mediated dilation was not different between groups, neither was endothelium-
independent dilation. The difference did not become significant neither introducing baseline 
arterial diameter as a covariate, nor introducing GTN-induced dilation as a covariate in 
FMD analysis (p=ns). 
All data from ultrasound evaluation of the common carotid show no difference in vessel 
size, structure, or elasticity. 
With echocardiography, the two groups were comparable as for left ventricular mass and 
ejection fraction. (Note that echocardiographic parameters are at the time being available for 
baseline evaluation only.) 
 
 
 
  
Table 1. Non-MCI vs. MCI. 
 
    Non-MCI (n=40) MCI (n=98) p 
Sex, M/F  21/19 46/52 0.6 
Age, years  73.5 (4.7) 75.3 (4.9) 0.053 
BMI, Kg/m2  28.0 (5.8) 26.7 (4.0) 0.141 
Systolic blood pressure, mmHg  138.5 (16.6) 141.1 (17.4) 0.4 
Diastolic blood pressure, mmHg  73.8 (8.1) 72.9 (8.8) 0.7 
Pulse pressure, mmHg  64.8 (14.2) 68.2 (15.9) 0.2 
Heart rate, bpm  64.1 (8.2) 65.0 (10.8) 0.6 
Central systolic pressure, mmHg  128.1 (14.0) 127.1 (14.5) 0.7 
Central diastolic pressure, mmHg 74.7 (8.3) 71.9 (8.6) 0.089 
Central pulse pressure, mmHg  53.3 (11.1) 55.2 (13.6) 0.4 
Mean pressure, mmHg  96.7 (10.1) 94.4 (9.5) 0.2 
Augmentation pressure, mmHg  18.3 (6.0) 17.7 (7.6) 0.7 
Augmentation index, %  34.3 (9.7) 31.3 (8.4) 0.078 
Pulse wave velocity, m/s  10.23 (2.33) 10.74 (2.63) 0.3 
Brachial artery diameter, mm  4.12 (0.79) 4.31 (0.85) 0.3 
Flow mediated dilation, %  3.78 (2.12) 3.01 (2.08) 0.064 
Dilation to nitroglycerin, %  7.60 (4.46) 6.54 (3.63) 0.175 
Carotid diameter, mm  7.88 (0.84) 8.02 (0.85) 0.4 
Intima-media thickness, mm  0.757 (0.131) 0.776 (0.160) 0.5 
Wall cross sectional area, mm2  16.34 (3.60) 17.17 (4.20) 0.3 
Distension, mm  0.518 (0.127) 0.546 (0.155) 0.3 
Distensibility, Pa-1  19.66 (6.33) 20.28 (7.96) 0.7 
Compliance, mm2KPa-1  0.882 (0.253) 0.950 (0.363) 0.3 
Stiffness, m/s  7.48 (1.10) 7.47 (1.22) 1.0 
Elastic modulus, KPa  504.6 (181.6) 512.4 (229.5) 0.9 
Left ventricular mass index, g/m2 92.6 (18.0) 95.4 (18.5) 0.5 
Ejection fraction, %  60.9 (3.4) 61.2 (4.3) 0.7 
MCI: training vs. usual care 
 
Ninety patients had a viable cardiovascular evaluation both at baseline and after the 
intervention period: 54 in the training group, 36 in the non-training group (Table 2).  
There were no differences at baseline in age, BMI, peripheral or central pressure, pulse 
wave analysis, flow mediated dilation, or pulse wave velocity (all p=ns).  
The training group had higher cognitive impairment, measured as ADAS-Cog score, at 
baseline. ADAS-Cog had no significant correlation with endothelium-dependent or -
independent dilation, neither with pulse wave velocity or any parameter derived from 
carotid imaging (all p’s ≥0.137). 
The two groups were similar in carotid diameter and intima-media thickness, resulting in 
similar wall cross-sectional area. The non-training group happened to have higher net vessel 
distension: this was reflected in a significantly higher distensibility, while the differences in 
other parameters of elasticity such as compliance, stiffness, and Young’s modulus did not 
reach statistical significance (p’s between 0.073 and 0.106). 
 
 
 
  
Table 2. Non-training vs. Training. 
    Non-training (n=36) Training (n=54) p 
Sex, M/F  16/20 25/29 0.9 
Age, years  76.2 (5.6) 75.6 (4.8) 0.6 
BMI, Kg/m2  27.2 (4.3) 26.6 (3.7) 0.5 
ADAS-Cog score  11.95 (3.86) 14.32 (4.27) 0.010 
Systolic blood pressure, mmHg 140.4 (18.1) 141.3 (15.7) 0.8 
Diastolic blood pressure, mmHg 72.6 (10.0) 73.2 (8.1) 0.7 
Pulse pressure, mmHg  67.8 (17.3) 68.1 (13.4) 0.9 
Heart rate, bpm  67.6 (12.2) 64.0 (10.8) 0.156 
Central systolic pressure, mmHg 126.7 (11.5) 126.1 (13.4) 0.8 
Central diastolic pressure, mmHg 71.5 (8.7) 71.9 (8.6) 0.8 
Central pulse pressure, mmHg  55.2 (13.7) 54.2 (11.2) 0.7 
Mean pressure, mmHg  93.7 (8.1) 94.2 (9.8) 0.8 
Augmentation pressure, mmHg 17.1 (7.3) 17.6 (6.6) 0.7 
Augmentation index, %  30.8 (9.3) 31.6 (7.6) 0.6 
Pulse wave velocity, m/s  10.50 (2.66) 10.91 (2.76) 0.5 
Brachial artery diameter, mm  4.23 (0.91) 4.37 (0.84) 0.5 
Flow mediated dilation, %  3.20 (2.03) 2.82 (2.19) 0.5 
Dilation to nitroglycerin, %  7.07 (3.27) 6.19 (3.65) 0.5 
Carotid diameter, mm  8.00 (0.93) 8.07 (0.78) 0.7 
Intima-media thickness, mm  0.764 (0.176) 0.776 (0.153) 0.8 
Wall cross sectional area, mm2 16.74 (5.22) 17.22 (3.60) 0.6 
Distension, mm  0.63 (0.19) 0.52 (0.13) 0.009 
Distensibility, Pa-1  23.65 (11.39) 18.83 (5.38) 0.046 
Compliance, mm2KPa-1  1.973 (0.488) 0.889 (0.272) 0.073 
Stiffness, m/s  7.10 (1.51) 7.63 (0.99) 0.106 
Elastic modulus, KPa  445.2 (176.2) 538.3 (242.3) 0.087 
Left ventricular mass index, g/m2 90.6 (17.7) 98.2 (19.0) 0.084 
Ejection fraction, %  61.3 (3.9) 61.5 (4.3) 0.9 
After the 7-months period, ADAS-Cog increased in the non-training and decreased in the 
training group, with statistical significance for both the time/treatment interaction and the 
intra-group comparisons, thus showing a positive effect of the intervention: 11.95 ± 3.86 to 
13.00 ± 4.73 for no training, p=0.030; 14.32 ± 4.27 to 12.85 ± 4.03 for training, p=0.003; 
time x treatment p<0.001. The net variation in ADAS-Cog between the end and the 
beginning of the study period had no significant correlation with variations in vascular 
parameters, except with that in carotid diameter (r=0.28, p=0.016; all other p’s ≥0.09). 
Patients were also dichotomized to improved or non-improved according to a change in 
time above or below zero: there was no significant correlation at the chi-square test between 
improvement in ADAS-Cog and those in FMD, carotid distension, or elastic modulus (p’s 
≥0.34) 
 
There was no significant effect of the combination of time and treatment on systolic, 
diastolic, or pulse pressure (all p’s =.38 or more). At the intra-group comparison, the non-
training group had a significant decrease in diastolic pressure only (72.6 ± 10.0 to 68.3 ± 9.7 
mmHg, p=0.048) while the training group showed a decrease in time of both systolic and 
diastolic (SBP: 141.3 ± 15.7 to 134.1 ± 14.6 mmHg, p=0.001; DBP: 73.2 ± 8.1 to 69.0 ± 
9.1, p<0.001).  
 
There was no difference of behavior in time of carotid-femoral pulse wave velocity (p=0.5; 
Figure 1a); it decreased significantly in both groups (p=0.022 for no training, p=0.015 for 
training).  
 
 
 
  
Figure 1. PWV and FMD. 
 
 
 
a., carotid-femoral pulse wave velocity. No training: from 10.50 (2.66) to 9.51 (1.65) m/s; training: 
from 10.91 (2.76) to 10.23 (1.94). 
b., brachial flow-mediated dilation. No training: from 3.20 (2.03) to 2.50 (1.77) %; training: from 
2.82 (2.19) to 3.42 (1.82). 
† = p<0.05 for interaction time x treatment;  * = p<0.05 for intra-group variation. 
There was a significant diverging behavior in FMD between the two groups (p=0.014, 
Figure 1b). The decreasing trend in the non-training group and the increasing trend in the 
training group did not reach statistical significance (p=0.054 and p=0.075, respectively). 
GTN or brachial diameter showed no difference or change (all p’s =0.2 or more). 
 
A diverging trend was statistically significant for diameter of the common carotid (p=0.014, 
Figure 2a). It increased in the non-training group and decreased in the training group 
(p=0.047 and p=0.049, respectively; Figure 2a). 
The effect of the combination of time and treatment was significant also for intima-media 
thickness (p=0.049, Figure 2b), without statistical significance for intra-group comparison 
(p=0.121 or more). 
These variations in vessel diameter and thickness determined a significant difference in 
behavior of wall cross-sectional area (p=0.012, Figure 2b; p=0.074 or more for intra-group 
comparisons). 
 
 
 
  
Figure 2. Carotid diameter, intima-media thickness and wall cross-sectional area. 
 
 
a., carotid diameter. No training: from 8.00 (0.93) to 8.18 (0.87) mm; training: from 8.07 (0.78) to 
7.88 (0.86). 
b., intima-media thickness. No training: from 0.764 (0.176) to 0.821 (0.165) mm; training: from 
0.776 (0.153) to 0.756 (0.115) . 
c., wall cross-sectional area. No training: from 16.74 (5.22) to 18.31 (5.04) mm2; training: from 
17.22 (3.60) to 16.30 (3.41) . 
† = p<0.05 for interaction time x treatment;  * = p<0.05 for intra-group variation. 
 
 
 
The analysis of distension showed a significant divergence with time (p=0.005), with a 
significant decrease in time of the non-training group (no training: 0.63 ± 0.19 to 0.51 ± 
0.13 mm, p=0.013; training: 0.52 ± 0.13 to 0.52 ± 0.16, p=1.0). It has to be pointed out that 
there was no difference or change in carotid pulse pressure (no training: from 60.5 ± 17.9 to 
55.9 ± 14.1 mmHg, p=0.140; training: from 57.4 ± 13.8 to 54.5 ± 11.8, p=0.124; baseline 
difference: p=0.5; time x treatment: p=0.6). 
Time x treatment had a significant effect on distensibility (p=0.002; Figure 3a). 
Distensibility decreased at the intra-group comparison in the standard care group (p=0.024).  
The analyses of compliance also showed a significant effect of time and treatment (p=0.029; 
no training: from 1.07 ± 0.48 to 0.87 ± 0.27 mm2kPa-1, p=0.086; training: from 0.89 ± 0.27 
to 0.91 ± 0.32, p=0.7), as it was the case for stiffness (p=0.013; no training: from 7.10 ± 
1.51 to 7.75 ± 1.32 m/s, p=0.092; training: from 7.63 ± 0.99 to 7.45 ± 1.10, p=0.3). 
Young’s elastic modulus was subject to the combined effect of time and treatment (p=0.023, 
Figure 3b), without a significant change at the intra-group comparison (no training: from 
445.2 ± 176.2 to 529.8 ± 212.0 KPa, p=0.080; training: from 538.3 ± 242.3 to 500.2 ± 
166.8, p=0.3). 
 
 
 
  
Figure 3. Carotid distensibility and elastic modulus. 
 
 
 
 
a., carotid distensibility coefficient. No training: from 23.65 (11.39) to 18.27 (6.07) KPa-1 ; training: 
from 18.83 (5.38) to 20.14 (6.71). 
b., Young’s elastic modulus. No training: from 445.2 (176.2) to 529.8 (212.0) KPa; training: from 
538.3 (242.3) to 500.2 (166.8) (one data point is outside the axis limits at baseline). 
† = p<0.05 for interaction time x treatment;  * = p<0.05 for intra-group variation. 
Discussion 
 
The main result from the vascular analysis in the Train the Brain study is that a 7-month 
comprehensive program of cognitive and physical training is able to produce detectable 
changes in the vasculature of elder subjects with mild cognitive impairment, compared to 
peers assigned to standard care. These variations oppose the usual patho-physiological 
effects of aging on vessels, i.e. progressive endothelial dysfunction, dilation, wall 
thickening, and loss of elasticity (Lakatta 2002). 
 
The initial evaluation, aimed at characterizing the cardiovascular status of the population to 
detect differences between MCI and normal subjects in the same age span, did not show any 
significant difference. In particular, there was no difference in endothelial function, as 
measured through flow-mediated dilation. 
Nitric oxide plays an important role in the regulation of the cerebral circulation. 
Pharmacological blockade of NO synthesis reduces cerebral flow (White, Vallance et al. 
2000); in healthy subjects, cerebral activity during a verbal memory test, measured by 
fMRI, is correlated with endothelial function in the brachial artery (Gonzales, Tarumi et al. 
2010). As for cognitive impairment, the reactivity of skin microcirculation – another method 
to estimate endothelial function – is reduced in AD subjects, in comparison to healthy peers, 
and altered also in initial cognitive impairment (Khalil, LoGiudice et al. 2007); adhesion 
molecules, a marker of endothelial activation, are altered both in overt cerebrovascular 
disease and in dementia, to further suggest a common patho-physiology (Zuliani, Cavalieri 
et al. 2008). In general, however, the relationship between endothelial function and 
cognitive losses seems to have been underinvestigated and mostly speculative. 
We found no specific study linking flow mediated dilation of the brachial artery and the 
development of dementia: the analysis in the Train the Brain study is the first of this kind. 
The group with mild cognitive impairment did not differ in FMD from that without. The 
finding seems in contrast with the hints from the above-mentioned previous studies; it has to 
be noticed, however, that the FMD values found in the present population are low in 
average – as expected in elders, since age is the main contributor to endothelial dysfunction 
– with some subjects even having a barely detectable response. With low values, higher is 
the relative contribution of intrinsic variability and errors of the methodology, so that the 
analysis is performed around its resolution limits. This could have concurred in finding a 
difference between groups that just misses statistical significance (p=0.064, Table 1): a few 
more subjects could perhaps have changed the result. 
 
Much more investigated and solid is the relationship between arterial stiffness and cognitive 
decline – although different districts, measurements and biomarkers have been studied (de 
la Torre 2002, Luchsinger, Reitz et al. 2005, Waldstein, Rice et al. 2008, Mitchell 2011, 
Mitchell, van Buchem et al. 2011, Zlokovic 2011, Pase, Herbert et al. 2012) – and between 
cognitive decline and atherosclerotic burden in the carotid artery (Hofman, Ott et al. 1997, 
Haley, Forman et al. 2007, Wendell, Zonderman et al. 2009, Baracchini, Mazzalai et al. 
2012). In the Train the Brain study, when the two groups with and without MCI were 
compared, no difference was apparent in carotid-femoral pulse wave velocity, neither in 
common carotid size, structure and function. A possible explanation is that in this 
population the effect of age – the main contributor to arterial stiffening in all populations 
and all studies – on large vessels is predominant at such an extent that it obscures the 
differences and any other contributor. It must be also noticed that other studies enrolled 
patients with more advanced cognitive deficits, thus comparing two well distinct groups 
(normal and dementia), while the present study enrolled an elder population and divided it 
in two according to a diagnosis of Mild Cognitive Impairment: patho-physiological 
differences are plausibly less pronounced (subjects with overt dementia were expressly 
excluded). 
  
It is known that cognitive and physical stimulation help in maintaining cognitive function. 
At the same time, the positive effect of physical exercise on the vasculature has been known 
for decades, and the link between cardiovascular health, vessel damage and cognitive fitness 
is by now beyond doubt, even if a lot has still to be elucidated. While the negative 
prognostic value of endothelial dysfunction, arterial stiffness and alterations in the carotid 
wall is established, their susceptibility to interventions is less widely known, and even less 
is a possible clinical meaning of their changes in time. 
We therefore hypothesized that the proposed program of physical and cognitive training 
could exert beneficial effects on the vessels, in addition to those (directly evident) on 
cognition. An improvement in arterial health could indeed be one of the mechanisms 
through cognitive health is maintained. 
 
Noteworthy, the present study demonstrated for the first time that a combined cognitive-
exercise training is able to increase carotid distensibility, and in general to counteract 
physiological aging in large vessels, including arterial dilation and thickening, in individuals 
with MCI. The design allowed detecting differences of behavior in time between the two 
groups, thus overcoming the need for the power to detect significant intra-group variations 
(which were, anyway, significant for some parameters). 
Carotid-femoral pulse wave velocity decreased in both groups, without differences in 
behavior. This result could be secondary to the lower pressure load, due to the similar 
decrease in blood pressure in the two groups. This parameters measures PWV mostly along 
the aorta, an elastic vessel with a low muscular component: possible changes in vessel 
composition could have needed a fiber rearrangement that needs more than seven months to 
show as a significant difference in PWV, especially if there is already a major change due to 
pressure decrease. 
 
An improvement was evident for endothelial function. The conclusion that the increase in 
percent FMD is due to the endothelium is supported by the fact that neither brachial artery 
diameter – a known determinant of percent dilation – neither GTN-induced dilation, used to 
estimate reactivity of smooth muscle cells, showed any change, and that by introducing 
these parameters as covariates in the analysis, variation was still significant for FMD. 
 
A change was apparent in all parameters calculated from ultrasound scanning of the 
common carotid, in the absence of a significant change in local distending pressure. The 
vessel kept progressively dilating in the non-training group, while the increase in size was 
reversed in the training group. Intima-media thickness showed a significant diverging 
behavior, with a trend to an increase in no-training, a decrease in the training group. The 
combination of the two led to another statistically significant finding, i.e. a trend to an 
increase in wall cross-sectional area without training, and to a decrease with training. 
 
As for elasticity, all parameters considered to measure it in the common carotid were 
consistent in showing a significant divergence, with a tendency towards stiffening with 
standard care, and towards a de-stiffening with training. This happens with the parameters 
considering elasticity of the vessel as a whole, but also with Young’s elastic modulus, that is 
a measure of intrinsic stiffness of the vessel components. Taken altogether, these results 
suggest that the intervention produced anatomical and functional changes in the common 
carotid, both quantitative (as seen with WCSA) and qualitative (as seen with Young’s 
modulus), and the changes in elasticity derive from a combination of the two. Given also the 
data for endothelial function, the known role of the endothelium in modulating vessel 
function and composition can be hypothesized to have played a role. 
 
This is the first study to have performed a comprehensive vascular characterization at two 
distinct time points in such a population. Findings from the carotid artery are a novelty: they 
constitute the evidence of the effectiveness, in terms of changes in vessels, of a rather short-
term and low-intensity intervention. It has to be kept in mind that elders do not have the 
same vessel plasticity as it can be expected in younger adults – especially not completely 
healthy elders, such as these. On the other hand, the intervention program was not 
particularly intense, neither time consuming, as it had to be appropriate for all of the elder 
population. 
Since the program was a combination of physical and cognitive training, the relative 
contribution of the two activities to the observed changes can not be discriminated. The 
importance of physical activity for vessel health can never be overrated, but also the 
interplay between cerebral activity and blood flow in the afferent vessels has been 
extensively discussed. Additional study arms with only one intervention component would 
have been a practical problem, and, since the main aim and outcome of the study was 
cognitive function, the Train the Brain study tried to implement the combined strategies that 
proved to be the most effective in giving benefits (Fabel, Wolf et al. 2009, Paillard-Borg, 
Fratiglioni et al. 2012). It can not be excluded that some additive effect of the multi-
modality approach could have been reflected in the changes observed at the vascular 
analysis. 
 
In this context, it is a rather disappointing finding that, even if the intervention clearly 
improved both cognitive function (measured as ADAS-Cog) and vessel health, there seems 
to be no correlation between the two changes at the individual level. The study does not 
help in establishing and clarifying the link between vascular and cognitive health, and does 
not support the hypothesis that an intervention successful in improving vessel structure and 
function will automatically translate in slowing cognitive decay. A follow-up aimed at 
assessing the persistence of benefits would perhaps help, and it would be interesting to 
know if the changes have translated at least into a reduction in cardiovascular risk. 
 
In conclusion, a non-pharmacological, combined physical and cognitive training in a social 
setting slows, and partly reverses, the decline in cognitive abilities, endothelial function, and 
carotid anatomy and elasticity in a population of elders with mild cognitive impairment. 
Further analysis will be necessary to unravel the molecular factors underlying vascular 
changes in response to intervention and will also be necessary to understand whether and to 
which extent vascular stiffness is (causally?) related to cognitive function, what is the 
impact of its change and if it translates in a real prognostic benefit. 
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